Year
Edition number
№10 / 2020
REVIEWS
A.I. Sinopalnikov
Management of patients with community-acquired pneumonia in outpatient settings8-18
S.L. Babak, M.V. Gorbunova, A.G. Malyavin
Algorithm of respiratory support for COVID-19 patients19-26
E.I. Kakhiani (1), N.A. Korobkov (1), V.V. Vasiliev (1, 2), E.S. Romanova (1)
Therapeutic and diagnostic aspects of the new coronavirus infection COVID-19 in obstetric practice27-37
Yu.G. Belotserkovskaya (1), S.S. Lebedev (1), D.V. Vakatov (2), I.A. Demina (2), O. N. Sakara (2), A.G. Romanovskikh (1), I.P. Smirnov (1)
COVID-19: selected clinical aspects through the prism of practical experience38-51
O.V. Fesenko (1), O.A. Sibiryakova (1), S.N. Shvayko (2)
Treatment of a new coronavirus infection (COVID-19): opportunities and limitations52-60
A.I. Sinopalnikov
Formula for successful chronic obstructive pulmonary disease control61-71
ORIGINAL ARTICLES
E.A. Orlova, E.M. Kostina, O.A. Kulikova
Clinical experience of sublingual allergen-specific immunotherapy of allergic rhinitis in a coronavirus pandemic72-79
A.B. Pirogov, A.G. Prikhodko, N.L. Perelman, E.Yu. Afanasyeva, E.Yu. Kochegarova, L.Yu. Oshur, J.M. Perelman
Possibilities of achieving of bronchial asthma control against the background of baseline therapy with beclometasone/formoterol extrafine fixed combination: an open observational prospective study80-87
E.M. Kostina (1), E.Yu. Trushina (1), E.A. Orlova (1), N.I. Baranova (1), O.A. Levashova (2)
The role of leukotrienes in the pathogenesis of inflammation in patients with different phenotypes of bronchial asthma and chronic obstructive pulmonary disease88-93
D.F. Sergienko, P.B. Khishtilova
Bronchopulmonary dysplasia in children in terms of genetic variability of the vitamin D receptor94-99
I.V. Vyazovaya, S.D. Ikhsanov, I.A. Averina
Features of the course of chronic lung diseases in children at the present stage100-105
E.Yu. Trushina, E.M. Kostina
Indications for the administration of inhaled glucocorticosteroids in patients with chronic obstructive pulmonary disease106-110
R.A. Bontsevich (1, 2, 3), A.V. Adonina (1, 2), A.V. Mikhno (2, 4), D.I. Kutsenko (2), G.A. Batishcheva (5), Yu.M. Dronova (5), G.G. Ketova (6), V.O. Barysheva (6), E.V. Luchinina (7), E.V. Mironenko (8), G.M. Bikkinina (9), T.G. Pokrovskaya (1)
Bronchial asthma: assessment of knowledge of senior students. Final results of the ASSA-II study111-118
E.A. Orlova (1), E.M. Kostina (1), O.A. Kulikova (1), O.A. Levashova (2), S.A. Sokolov (3)
Comparative assessment of leukotriene levels in different forms of rhinitis120-124
N.M. Nenasheva (1), S.V. Fedosenko (2, 3), E.N. Barabanova (3)
Efficacy and safety of mepolizumab in patients with bronchial asthma in real clinical practice125-132
D.V. Bestaev (1), Z.S. Brtsieva (1), S.A. Ktsoeva (1), L.M. Khutieva (1), N.N. Burduli (1), O.T. Kotsoeva (1), T.D. Bestaeva (2)
Some aspects of interstitial lung disease associated with leflunomide therapy in patients with rheumatoid arthritis133-135
